The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Eliquis 2.5 mg film-coated tablets

Bristol-Myers Squibb Pharma EEIGEU/1/11/691/001-005, 013

Main Information

Trade NameEliquis 2.5 mg film-coated tablets
Active SubstancesApixaban
Dosage FormFilm-coated tablet
Licence HolderBristol-Myers Squibb Pharma EEIG
Licence NumberEU/1/11/691/001-005, 013

Group Information

ATC CodeB01AF Direct factor Xa inhibitors
B01AF02 apixaban


License statusAuthorised
Licence Issued18/05/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - HCP

Educational Materials - Patient

Generics Information

Interchangeable List CodeIC0124-018-003
Interchangeable List DocumentPDF of Interchangeable List
« Back